Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?

Other users also viewed these articles

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık

10.1016/j.reumae.2023.11.002

Two-year Incidence of Psoriasis, Uveitis and Inflammatory Bowel Disease in Patients With Spondyloarthritis: A Study in the AQUILES Cohort Rosario García-Vicuña, Pedro Zarco, Carlos M. González, Francisco Vanaclocha, Ignacio Marín-Jiménez, Luis Cea-Calvo

10.1016/j.reumae.2015.03.011

Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up Juan D. Cañete, Antonio Naranjo, Javier Calvo, Carmen Ordás, Belén Aragón, Gonzalo Nocea, Montse Roset, Antonio Fernández-Nebro

10.1016/j.reumae.2018.11.016